82 related articles for article (PubMed ID: 2681876)
1. [Expression of the epidermal growth factor receptor in esophageal cancer].
Mukaida H; Hirai T; Toi M; Nakamura T; Yamashita Y; Kawano K; Toge T; Niimoto M; Hattori T
Gan No Rinsho; 1989 Oct; 35(12):1399-406. PubMed ID: 2681876
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
3. High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas.
Ozawa S; Ueda M; Ando N; Abe O; Shimizu N
Int J Cancer; 1987 Mar; 39(3):333-7. PubMed ID: 3493224
[TBL] [Abstract][Full Text] [Related]
4. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
[TBL] [Abstract][Full Text] [Related]
5. Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma.
Yano H; Shiozaki H; Kobayashi K; Yano T; Tahara H; Tamura S; Mori T
Cancer; 1991 Jan; 67(1):91-8. PubMed ID: 1702347
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer.
Mukaida H; Toi M; Hirai T; Yamashita Y; Toge T
Cancer; 1991 Jul; 68(1):142-8. PubMed ID: 2049734
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
Inada S; Koto T; Futami K; Arima S; Iwashita A
Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
Ueda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGF-R) in invasive cervical cancer of the uterus].
Sugimura M; Kobayashi H; Kanayama N; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):689-94. PubMed ID: 1506731
[TBL] [Abstract][Full Text] [Related]
10. Progression of esophageal carcinoma by loss of EGF-STAT1 pathway.
Watanabe G; Kaganoi J; Imamura M; Shimada Y; Itami A; Uchida S; Sato F; Kitagawa M
Cancer J; 2001; 7(2):132-9. PubMed ID: 11324766
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas.
Ozawa S; Ueda M; Ando N; Shimizu N; Abe O
Cancer; 1989 Jun; 63(11):2169-73. PubMed ID: 2720567
[TBL] [Abstract][Full Text] [Related]
12. Expression of human epidermal growth factor and its receptor in esophageal cancer.
Mukaida H; Yamamoto T; Hirai T; Toi M; Nakamura T; Wada T; Yamashita Y; Kawano K; Niimoto M
Jpn J Surg; 1990 May; 20(3):275-82. PubMed ID: 2193179
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
14. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
16. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.
Tateno T; Ueno S; Hiwatashi K; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Sakoda M; Kubo F; Ishigami S; Shinchi H; Natsugoe S
Ann Surg Oncol; 2009 Feb; 16(2):440-6. PubMed ID: 19023628
[TBL] [Abstract][Full Text] [Related]
17. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
18. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
[TBL] [Abstract][Full Text] [Related]
19. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
20. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
